All Hong Kong stocks quotes are at least 15 minutes delayed.
01299
AIA
HKD
90.350-0.600
(-0.66%)
1D
AI Analysis for 01299
AI Analysis
High
92.100
Open
90.500
VWAP
91.00
Vol
41.00M
Mkt Cap
830.00B
Low
90.050
Amount
4.00B
EV/EBITDA(TTM)
13.00
Total Shares
11.00B
EV
133.00B
EV/OCF(TTM)
22.00
P/S(TTM)
5.00
AIA Group Ltd is an investment holding company mainly engaged in the life insurance and health insurance business. The Company provides individual and group life insurance, accident and health insurance, savings and retirement products, and offers related services including employee benefits, credit insurance and wealth management. The Company operates across multiple Asian markets through its subsidiaries and joint ventures.
Show More
News
6.0
04:01 AMaastocksG Sachs Raises AIA (01299.HK) Price Target to $96, Maintains Buy Rating
AIA's Share Performance: AIA's share price has increased by 62% over the past year, currently valued at 1.4x the projected 1-year PEV, reaching a new high for 2023 but still below the 1.7x average from 2013-2023.
Goldman Sachs Outlook: Goldman Sachs maintains a positive outlook on AIA, raising its target price from $85 to $96 and reaffirming a "Buy" rating, citing the company's strong growth potential despite market concerns.
6.5
01-29aastocksCiti Raises AIA (01299.HK) Price Target to $103, Anticipates 19% Increase in 2025 NBV
AIA's Growth Forecast: Citi Research predicts AIA's new business value will grow by 19% YoY in 2025, driven by strong performance in Hong Kong, Thailand, and Singapore.
Operating Profit Expectations: The broker forecasts an 8% increase in AIA's operating profit for 2025, with operating profit per share expected to rise by 12%, exceeding management's guidance.
Dividend and Buyback Projections: AIA's full-year dividend per share is estimated to increase by 10% to $1.94, with share buybacks projected at approximately $1.3 billion.
Target Price Adjustment: Citi Research raised AIA's target price from $99 to $103, maintaining a "Buy" rating on the stock.
4.5
01-29aastocksMidday Update: HSI Ends at 27,975, Gaining 148 Points; HSTI at 5,860, Dropping 39 Points; SANDS CHINA LTD Falls Over 7%; XINYI GLASS, ZIJIN MINING, CNOOC, HENDERSON LAND, AIA Reach New Peaks
Market Performance: The HSI rose by 148 points (0.5%) to 27,975, while the HSTI fell by 39 points (0.7%) to 5,860, and the HSCEI increased by 43 points (0.5%) to 9,555.
Active Heavyweights: Notable stock movements included PING AN (+1.9%), XIAOMI (+1.5%), and CCB (+1.5%), while BABA saw a slight decline of 0.2%.
Significant Movers: SANDS CHINA LTD dropped significantly by 7.3%, whereas LONGFOR and XINYI GLASS saw gains of 5.6% and 5.1%, respectively, with XINYI hitting a new high.
High Performers in HSMI & HSSI: LOGAN GROUP surged by 29.1%, SUNAC by 27.2%, and COUNTRY GARDEN by 20%, indicating strong performance among certain stocks in the market.
6.5
01-29aastocksJPM: AIA (01299.HK) Surpasses Market Performance in the Last Year; Possible Earnings Forecast Increase Could Drive Valuation Growth
AIA's Market Performance: AIA has outperformed the market with a 63% increase over the past 12 months, significantly surpassing the HSI's 37% rise, according to a JPMorgan report.
Impact of USD Weakness: The company is benefiting from a weakening USD, and potential increases in future business growth forecasts could further enhance its valuation.
Target Price Adjustment: JPMorgan has raised AIA's target price to $115 while maintaining an Overweight rating, anticipating better performance in Hong Kong, mainland China, and Thailand markets.
Future Growth Expectations: The expected disclosure of data from AIA's joint venture in India is likely to support upgrades to its new business value growth forecasts for FY2026/2027.
7.0
01-28aastocksM Stanley Positive About AIA (01299.HK) Earnings Forecast, Raises Target Price to $111
Morgan Stanley's Outlook on AIA: Morgan Stanley maintains an optimistic outlook on AIA, raising its target price by 16% to $111 and keeping the rating at Overweight, citing strong new business value growth expected in 2025.
Projected Growth Figures: AIA's new business value is forecasted to reach $5.58 billion in 2025, reflecting an 18% year-over-year increase, driven by significant growth in the Hong Kong, Thailand, and Singapore markets.
Money Flow
Over the past 66 trading days, overall net money flow is 1.00B, with retail investors contributing 26.00M and major investors adding 1.00B.
Net Buy $ Volume
Net Sell $ Volume
Citi Research
NULL -> Buy
upgrade
$99 -> $103
2026-01-29
New
Reason
The analyst rating from Citi Research is based on the expectation that AIA will release solid 2025 results, driven by significant growth in its operations in Hong Kong, Thailand, and Singapore. The report predicts a 19% year-over-year growth in new business value, an 8% increase in operating profit, and a 12% rise in operating profit per share, all of which surpass management's guidance. Additionally, the anticipated 12% increase in embedded value and a projected 10% rise in full-year dividends per share further support the positive outlook. As a result, Citi Research raised its target price for AIA and maintained a "Buy" rating.
Citi Research
NULL -> Buy
Price Target
$99 -> $103
2026-01-29
upgrade
New
The analyst rating from Citi Research is based on the expectation that AIA will release solid 2025 results, driven by significant growth in its operations in Hong Kong, Thailand, and Singapore. The report predicts a 19% year-over-year growth in new business value, an 8% increase in operating profit, and a 12% rise in operating profit per share, all of which surpass management's guidance. Additionally, the anticipated 12% increase in embedded value and a projected 10% rise in full-year dividends per share further support the positive outlook. As a result, Citi Research raised its target price for AIA and maintained a "Buy" rating.
JPMorgan
JPMorgan
maintain
$115
2026-01-29
New
Reason
The analyst rating for AIA (01299.HK) is maintained at "Overweight" due to several key reasons highlighted in the JPMorgan report:
1. Strong Performance: AIA has outperformed the market over the past 12 months, with a total increase of 63%, significantly surpassing the HSI's rise of approximately 37%.
2. Beneficiary of Weakening USD: AIA is identified as a major beneficiary of the weakening US dollar, which could positively impact its financial performance.
3. Potential for Increased Business Growth Forecasts: There is an expectation that the market may raise its future business growth forecasts for AIA, which could serve as a catalyst for further valuation increases.
4. Positive Market Outlook: Anticipation of better performance in key markets such as Hong Kong, mainland China, and Thailand, along with potential data disclosures from a joint venture in India, supports upgrades to AIA's new business value growth forecasts for FY2026/2027.
5. Target Price Increase: JPMorgan has raised its target price for AIA to $115, reflecting confidence in the company's growth prospects.
These factors collectively contribute to the positive analyst rating and outlook for AIA.
JPMorgan
Price Target
$115
2026-01-29
maintain
New
The analyst rating for AIA (01299.HK) is maintained at "Overweight" due to several key reasons highlighted in the JPMorgan report:
1. Strong Performance: AIA has outperformed the market over the past 12 months, with a total increase of 63%, significantly surpassing the HSI's rise of approximately 37%.
2. Beneficiary of Weakening USD: AIA is identified as a major beneficiary of the weakening US dollar, which could positively impact its financial performance.
3. Potential for Increased Business Growth Forecasts: There is an expectation that the market may raise its future business growth forecasts for AIA, which could serve as a catalyst for further valuation increases.
4. Positive Market Outlook: Anticipation of better performance in key markets such as Hong Kong, mainland China, and Thailand, along with potential data disclosures from a joint venture in India, supports upgrades to AIA's new business value growth forecasts for FY2026/2027.
5. Target Price Increase: JPMorgan has raised its target price for AIA to $115, reflecting confidence in the company's growth prospects.
These factors collectively contribute to the positive analyst rating and outlook for AIA.
Morgan Stanley
Morgan Stanley
Overweight
maintain
$96 -> $111
2026-01-28
New
Reason
Morgan Stanley maintained an optimistic outlook on AIA (01299.HK) and lifted its target price by 16% to $111, citing strong growth in the company's new business value for 2025, which is expected to rise by 17% on a constant exchange rate basis. The report highlighted that AIA's new business value is forecasted to reach US$5.58 billion, driven by significant growth in key markets such as Hong Kong, Thailand, and Singapore, with growth rates of 28%, 19%, and 19%, respectively. Despite a slight normalization in growth in the fourth quarter of 2025 to 13%, the overall performance remained robust, with expectations for a 13% increase in full-year operating profit and an 18% increase in embedded value per share. This strong performance and growth potential laid a solid foundation for 2026, justifying the Overweight rating.
Morgan Stanley
Overweight
Price Target
$96 -> $111
2026-01-28
maintain
New
Morgan Stanley maintained an optimistic outlook on AIA (01299.HK) and lifted its target price by 16% to $111, citing strong growth in the company's new business value for 2025, which is expected to rise by 17% on a constant exchange rate basis. The report highlighted that AIA's new business value is forecasted to reach US$5.58 billion, driven by significant growth in key markets such as Hong Kong, Thailand, and Singapore, with growth rates of 28%, 19%, and 19%, respectively. Despite a slight normalization in growth in the fourth quarter of 2025 to 13%, the overall performance remained robust, with expectations for a 13% increase in full-year operating profit and an 18% increase in embedded value per share. This strong performance and growth potential laid a solid foundation for 2026, justifying the Overweight rating.
CICC
CICC
maintain
2026-01-27
New
Reason
The analyst rating is influenced by a recent policy package issued by the Insurance Association of China, the China Association of Actuaries, and the China Banking and Insurance Information Technology Management. This package aims to improve key infrastructure in commercial health insurance, addressing critical issues such as pricing data, product design, and information sharing. The broker, CICC, believes that these measures will help overcome long-standing obstacles in the industry, which have led to a cycle of low product value creation and funding efficiency. As a result, the analyst sees potential for a positive shift in the industry, recommending investors focus on opportunities in leading internet platforms, insurance groups, brokerage channels, reinsurers, and pharmaceutical enterprises that can benefit from the anticipated improvements in the health insurance market.
CICC
Price Target
2026-01-27
maintain
New
The analyst rating is influenced by a recent policy package issued by the Insurance Association of China, the China Association of Actuaries, and the China Banking and Insurance Information Technology Management. This package aims to improve key infrastructure in commercial health insurance, addressing critical issues such as pricing data, product design, and information sharing. The broker, CICC, believes that these measures will help overcome long-standing obstacles in the industry, which have led to a cycle of low product value creation and funding efficiency. As a result, the analyst sees potential for a positive shift in the industry, recommending investors focus on opportunities in leading internet platforms, insurance groups, brokerage channels, reinsurers, and pharmaceutical enterprises that can benefit from the anticipated improvements in the health insurance market.
JPMorgan
JPMorgan
Overweight
maintain
$40
2026-01-19
Reason
The analyst rating from JPMorgan is based on the observation that Asian insurers, particularly those in Hong Kong and China, have shown stronger price performance year-to-date compared to their respective market indices. The report highlights that these insurers have experienced an average price increase of 8%, which is more favorable than the performance of the Hang Seng Index (HSI) and Shanghai Composite Index (SHCOMP). In contrast, South Korean insurers have seen a decline, which further emphasizes the relative strength of the Hong Kong/China market.
JPMorgan believes that emerging markets (EMs) in Asia, excluding Japan and Australia, offer more favorable risk-reward characteristics due to stronger fundamental momentum, including improvements in earnings, growth, and solvency capital. The preference for life insurers over non-life and reinsurers is attributed to less favorable cyclical underwriting cycles and pricing trends for the latter since the beginning of the year.
Overall, the positive ratings for specific insurers like AIA, China Life, and Ping An reflect JPMorgan's confidence in their growth potential and financial stability in the current market environment.
JPMorgan
Overweight
Price Target
$40
2026-01-19
maintain
The analyst rating from JPMorgan is based on the observation that Asian insurers, particularly those in Hong Kong and China, have shown stronger price performance year-to-date compared to their respective market indices. The report highlights that these insurers have experienced an average price increase of 8%, which is more favorable than the performance of the Hang Seng Index (HSI) and Shanghai Composite Index (SHCOMP). In contrast, South Korean insurers have seen a decline, which further emphasizes the relative strength of the Hong Kong/China market.
JPMorgan believes that emerging markets (EMs) in Asia, excluding Japan and Australia, offer more favorable risk-reward characteristics due to stronger fundamental momentum, including improvements in earnings, growth, and solvency capital. The preference for life insurers over non-life and reinsurers is attributed to less favorable cyclical underwriting cycles and pricing trends for the latter since the beginning of the year.
Overall, the positive ratings for specific insurers like AIA, China Life, and Ping An reflect JPMorgan's confidence in their growth potential and financial stability in the current market environment.
Goldman Sachs
maintain
$110
2026-01-08
Reason
The analyst rating for AIA (01299.HK) is based on optimism regarding the company's growth prospects in mainland China and Hong Kong for 2026, driven by strong sales momentum and a positive profit margin outlook. Goldman Sachs highlighted these factors in their research report. Additionally, despite potential challenges in the Thai market due to high base effects impacting new business growth from 4Q25 to 1H26, the overall sentiment remains positive, leading to a "Buy" rating with a target price of $85.
Goldman Sachs
Price Target
$110
2026-01-08
maintain
The analyst rating for AIA (01299.HK) is based on optimism regarding the company's growth prospects in mainland China and Hong Kong for 2026, driven by strong sales momentum and a positive profit margin outlook. Goldman Sachs highlighted these factors in their research report. Additionally, despite potential challenges in the Thai market due to high base effects impacting new business growth from 4Q25 to 1H26, the overall sentiment remains positive, leading to a "Buy" rating with a target price of $85.
CLSA
CLSA
Outperform
maintain
$110
2026-01-06
Reason
The analyst rating from CLSA for AIA (01299.HK) is based on several key factors:
1. Long-term Quality Earnings Growth: CLSA appreciates AIA's ability to achieve sustainable earnings growth over the long term.
2. Shareholder Returns: The report highlights AIA's commitment to delivering returns to shareholders.
3. Shift in Strategy: CLSA believes that AIA's transition from new business investment to focusing on organic growth and reducing buybacks will enhance long-term shareholder value.
4. Target Price and Rating: Despite lowering its earnings forecast due to capital market volatility, CLSA maintains a target price of $110 and an "Outperform" rating, indicating confidence in AIA as a top pick in the Asian insurance sector.
5. Key Strategic Initiatives: The report points to important factors to monitor, such as strategic and leadership initiatives from AIA's new chairman, growth in Hong Kong's new business value, and strategies for new business in mainland China, as well as details on the joint venture in India.
Overall, the rating reflects a positive outlook on AIA's strategic direction and potential for growth, despite current market challenges.
CLSA
Outperform
Price Target
$110
2026-01-06
maintain
The analyst rating from CLSA for AIA (01299.HK) is based on several key factors:
1. Long-term Quality Earnings Growth: CLSA appreciates AIA's ability to achieve sustainable earnings growth over the long term.
2. Shareholder Returns: The report highlights AIA's commitment to delivering returns to shareholders.
3. Shift in Strategy: CLSA believes that AIA's transition from new business investment to focusing on organic growth and reducing buybacks will enhance long-term shareholder value.
4. Target Price and Rating: Despite lowering its earnings forecast due to capital market volatility, CLSA maintains a target price of $110 and an "Outperform" rating, indicating confidence in AIA as a top pick in the Asian insurance sector.
5. Key Strategic Initiatives: The report points to important factors to monitor, such as strategic and leadership initiatives from AIA's new chairman, growth in Hong Kong's new business value, and strategies for new business in mainland China, as well as details on the joint venture in India.
Overall, the rating reflects a positive outlook on AIA's strategic direction and potential for growth, despite current market challenges.
CMBI
CMBI
Outperform
maintain
2025-12-09
Reason
The analyst rating is based on the recent adjustment of risk factors by China's National Administration of Financial Regulation (NAFR), which lowers the solvency risk factors for insurers investing in specific indices. This regulatory change is seen as a move to guide insurance funds into the equity market, which is expected to benefit companies like PING AN and CHINA LIFE. The broker, CMBI, maintains an optimistic outlook for the insurance industry through FY2026, leading to their "Outperform" rating for the sector. Additionally, they recommend a "Buy" on several insurance stocks, indicating confidence in their growth potential following the policy changes.
CMBI
Outperform
Price Target
2025-12-09
maintain
The analyst rating is based on the recent adjustment of risk factors by China's National Administration of Financial Regulation (NAFR), which lowers the solvency risk factors for insurers investing in specific indices. This regulatory change is seen as a move to guide insurance funds into the equity market, which is expected to benefit companies like PING AN and CHINA LIFE. The broker, CMBI, maintains an optimistic outlook for the insurance industry through FY2026, leading to their "Outperform" rating for the sector. Additionally, they recommend a "Buy" on several insurance stocks, indicating confidence in their growth potential following the policy changes.
CLSA
CLSA
Hold
to
Outperform
upgrade
$33
2025-11-21
Reason
The analyst rating from CLSA is based on a positive outlook for Chinese and Hong Kong financial stocks in 2026, driven by expectations of economic growth transformation in China. The report emphasizes a preference for companies that can leverage differentiated growth models and unique driving factors. CLSA has upgraded CHINA LIFE's rating from Hold to Outperform, reflecting confidence in its potential to benefit from these trends. Additionally, target prices for other recommended stocks have been raised, indicating a broader optimism for the financial sector.
CLSA
Hold
to
Outperform
Price Target
$33
2025-11-21
upgrade
The analyst rating from CLSA is based on a positive outlook for Chinese and Hong Kong financial stocks in 2026, driven by expectations of economic growth transformation in China. The report emphasizes a preference for companies that can leverage differentiated growth models and unique driving factors. CLSA has upgraded CHINA LIFE's rating from Hold to Outperform, reflecting confidence in its potential to benefit from these trends. Additionally, target prices for other recommended stocks have been raised, indicating a broader optimism for the financial sector.
JPMorgan
maintain
$105 -> $107
2025-11-05
Reason
The analyst rating from JPMorgan is based on several key factors:
1. Strong Performance: AIA's strong new business value performance in the third quarter of 2025, with a notable recovery in mainland China's life insurance demand, which saw an average growth of 49% year-over-year for the first three quarters of 2025.
2. Improving Investor Confidence: The report indicates that investor confidence in the growth prospects and quality of the life insurance industry is improving, which is a positive sign for AIA.
3. Valuation Considerations: JPMorgan noted that AIA's current valuation is at 1.4 times the forecasted price-to-embedded value (P/EV) for fiscal year 2026, which is below the historical average of 1.7 times. This suggests potential for upward revisions in market consensus regarding new business value growth predictions for fiscal years 2025-2027.
4. Target Price Increase: As a result of these factors, JPMorgan raised its target price for AIA from $105 to $107 and maintained an "Overweight" rating, indicating a positive outlook for the stock.
Overall, the combination of strong business performance, improving market conditions, and favorable valuation metrics led to the positive analyst rating.
JPMorgan
Price Target
$105 -> $107
2025-11-05
maintain
The analyst rating from JPMorgan is based on several key factors:
1. Strong Performance: AIA's strong new business value performance in the third quarter of 2025, with a notable recovery in mainland China's life insurance demand, which saw an average growth of 49% year-over-year for the first three quarters of 2025.
2. Improving Investor Confidence: The report indicates that investor confidence in the growth prospects and quality of the life insurance industry is improving, which is a positive sign for AIA.
3. Valuation Considerations: JPMorgan noted that AIA's current valuation is at 1.4 times the forecasted price-to-embedded value (P/EV) for fiscal year 2026, which is below the historical average of 1.7 times. This suggests potential for upward revisions in market consensus regarding new business value growth predictions for fiscal years 2025-2027.
4. Target Price Increase: As a result of these factors, JPMorgan raised its target price for AIA from $105 to $107 and maintained an "Overweight" rating, indicating a positive outlook for the stock.
Overall, the combination of strong business performance, improving market conditions, and favorable valuation metrics led to the positive analyst rating.
Valuation Metrics
Forward PE
N/A
5Y Average PE
0.18
Current PE
0.00
Overvalued PE
1.78
Undervalued PE
-1.42
Forward EV/EBITDA
N/A
5Y Average EV/EBITDA
0.00
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
0.00
Undervalued EV/EBITDA
0.00
Forward PS
5Y Average PS
3.95
Current PS
5.04
Overvalued PS
4.94
Undervalued PS
2.96
Financials
AI Analysis
Annual
Quarterly
Trading Trends
Daily
Monthly
Buyback
Short Selling
People Also Watch